Latest Advances in Lung Cancer Research

Sotorasib Approved for KRAS G12C NSCLC. First FDA approved treatment for KRAS-positive non small cell lung cancer.

A new genomic study from the Ohio State University Cancer Center points to new treatment approaches for small-cell lung cancer.

A study shows promising results of a drug that helps the immune system fight cancer before surgery in patients with operable tumors.

An interview with Dr. Gregory Masters discussing the latest guidelines treating non-small cell lung cancer (NSCLC) with gene mutations.

Patients with non-small cell lung cancer with METex14 tumor have improved survival outcomes following savolitinib treatment.

Latest research shows the level of chromosomal abnormality in lung cancer patients may predict their immunotherapy response.

Researchers explain why there is an increase in never-smokers getting lung cancer – looking at risk factors contributing to the rise and the early symptoms.

Dr. Kathryn Gold discusses the latest insights on small-cell lung cancer guidelines from the National Comprehensive Cancer Network.

Requires Subscription now to view full article

How cancer patients are responding to the COVID vaccine. Results show poor response after first dose and empahsize need to avoid delay between doses.

Seeking to expand targeted therapy for lung cancer, Dr. Alice Berger, a recipient of a LCFA lung cancer research grant, has also received a NIH MERIT Award.

Latest in depth analysis and recommendations for lung cancer screening from the United States Preventive Services Task Force